Clinical trial

A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors

NCT07801508

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention [68Ga]Ga-DWJ155 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-09-08

PhasePHASE1

Conditions

Advanced Gastroesophageal Adenocarcinomaunresolved

Advanced Breast Cancerunresolved

Triple-negative Breast Cancerverified · MONDO: triple-negative breast carcinoma

Advanced Non-small Cell Lung Cancerunresolved

Interventions

[68Ga]Ga-DWJ155DIAGNOSTIC_TEST

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

KyotoJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07801508 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.